Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | O-6 methyl-guanine alkyl transferase, putative | 0.019 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.019 | 0 | 0.5 |
Mycobacterium tuberculosis | Methylated-DNA--protein-cysteine methyltransferase Ogt (6-O-methylguanine-DNA methyltransferase) (O-6-methylguanine-DNA-alkyltra | 0.0577 | 1 | 0.5 |
Chlamydia trachomatis | methylated-DNA protein-cysteine methyltransferase | 0.019 | 0 | 0.5 |
Treponema pallidum | methylated-DNA-protein-cysteine S-methyltransferase (dat) | 0.019 | 0 | 0.5 |
Trichomonas vaginalis | methylated-DNA--protein-cysteine methyltransferase, putative | 0.019 | 0 | 0.5 |
Trypanosoma cruzi | O-6 methyl-guanine alkyl transferase, putative | 0.019 | 0 | 0.5 |
Mycobacterium ulcerans | methylated-DNA--protein-cysteine methyltransferase Ogt | 0.0577 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.